In vitro study of Cefuroxime-Clavulanic Acid
Not Applicable
- Conditions
- Health Condition 1: A498- Other bacterial infections of unspecified site
- Registration Number
- CTRI/2024/01/061197
- Lead Sponsor
- Mankind Pharma Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Clinical isolates from non-repetitive clinical samples (such as blood, urine, pus, sputum,
etc.)
2. Successful evaluation of Minimum Inhibitory Concentration (MIC)
Exclusion Criteria
1. Isolates from repeat cultures of the same clinical sample
2. Non-fermenters or non-fermenting bacteria
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate in vitro susceptibility of clinical isolates to cefuroxime-clavulanic acid based on <br/ ><br>Minimum Inhibitory Concentration (MIC)Timepoint: Baseline
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI